Robert L Eil

Title: Robert L Eil: Innovator in T Cell Research

Introduction

Robert L Eil is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of immunology, particularly in the production of T cell populations. His innovative work has implications for cancer treatment and prevention.

Latest Patents

Robert L Eil holds a patent for "Methods of producing T cell populations using hydroxycitric acid and/or a salt thereof." This patent outlines methods for producing an isolated population of T cells by culturing them in vitro with hydroxycitric acid or its salts, such as potassium hydroxycitrate or sodium hydroxycitrate. The patent also includes related isolated populations of cells, pharmaceutical compositions, and methods for treating or preventing cancer in mammals. He has 1 patent to his name.

Career Highlights

Eil is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to explore innovative approaches to immunotherapy and cancer treatment.

Collaborations

Robert L Eil has collaborated with esteemed colleagues such as Suman Kumar Vodnala and Nicholas P Restifo. These collaborations have further enriched his research and contributed to advancements in the field.

Conclusion

Robert L Eil's contributions to T cell research and cancer treatment exemplify the impact of innovative thinking in the medical field. His work continues to inspire advancements in immunotherapy and offers hope for improved cancer therapies.